Registry for thoracic disease specimens
Thoracic Specimen Registry
Mayo Clinic · NCT04118660
This study is collecting samples from patients with lung diseases like lung cancer to help researchers learn more about these conditions and find better treatments.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 7000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Mayo Clinic (other) |
| Locations | 1 site (Rochester, Minnesota) |
| Trial ID | NCT04118660 on ClinicalTrials.gov |
What this trial studies
This registry aims to collect and store specimens from patients with thoracic diseases, including lung cancer and lung transplants, to support research on their causes, early diagnosis, and treatment. The specimens will include blood, bronchoalveolar lavage fluid, pleural fluid, and tissue samples. Managed by the Mayo Clinic Thoracic Specimen Registry Steering Committee, this initiative will facilitate the development of new research protocols and clinical trials to improve patient outcomes in thoracic diseases.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old with suspected or known thoracic diseases.
Not a fit: Patients without thoracic diseases or those under 18 years old may not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could lead to improved early diagnosis and treatment options for patients with thoracic diseases.
How similar studies have performed: Other studies utilizing specimen registries have shown success in advancing research and treatment in related fields.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subject must be \> 18 years of age * Presumed or known or screening of Thoracic Diseases (which includes but not limited to the following: thoracic neoplasms (masses/nodules) malignant or benign, interstitial lung diseases (ILD), chronic obstructive pulmonary disease (COPD), thoracic infections, thoracic malignancies metastatic to other organs, other cancers metastatic to the thoracic cavity.
Where this trial is running
Rochester, Minnesota
- Mayo Clinic in Rochester — Rochester, Minnesota, United States (RECRUITING)
Study contacts
- Principal investigator: Eric Edell, MD — Mayo Clinic
- Study coordinator: Aaron Bungum
- Email: Bungum.Aaron@mayo.edu
- Phone: 507-266-0078
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Thoracic Diseases, Lung Cancer, Lung Transplant